Published in Hepat Mon on October 16, 2016
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature (2009) 26.47
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus. Gastroenterology (2010) 6.14
Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol (2010) 5.78
Primary biliary cirrhosis. Hepatology (2009) 5.35
Alcoholic liver disease. Hepatology (2010) 5.04
EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol (2009) 4.45
Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med (2009) 3.70
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet (2011) 3.06
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology (2004) 2.64
Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology (2005) 2.15
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes. Hepatology (2011) 2.11
Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology (2006) 2.08
Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. Gastroenterology (1990) 1.76
Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity. Blood (2009) 1.75
The role of environmental factors in primary biliary cirrhosis. Trends Immunol (2009) 1.61
Primary biliary cirrhosis: a 2010 update. J Hepatol (2010) 1.57
Genetic factors of susceptibility and of severity in primary biliary cirrhosis. J Hepatol (2008) 1.56
Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology (2000) 1.55
Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology (1999) 1.52
IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease. J Hepatol (2012) 1.48
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology (2008) 1.40
Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut (2004) 1.31
Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol (1997) 1.27
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. Nat Commun (2015) 1.14
Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol (2007) 1.12
The epidemiology of primary biliary cirrhosis. Clin Liver Dis (2003) 1.09
Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study. Hepatology (2009) 1.01
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. Antivir Ther (2012) 1.01
IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. Haematologica (2011) 1.00
Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J Hepatol (2003) 0.97
Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review. Atherosclerosis (2007) 0.97
Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. Hepatology (2006) 0.96
Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activities. Int J Immunopathol Pharmacol (2004) 0.95
Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol (1994) 0.91
Prevalence and longterm course of primary biliary cirrhosis in primary Sjögren's syndrome. J Rheumatol (2008) 0.88
Genetics and genomics of primary biliary cirrhosis. Clin Liver Dis (2008) 0.86
The distribution of HLA antigens in Italy. Gene Geogr (1991) 0.86
Primary biliary cirrhosis is associated with oxidative stress and endothelial dysfunction but not increased cardiovascular risk. Hepatol Res (2010) 0.86
Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community. Eur J Gastroenterol Hepatol (2007) 0.83
Interstitial lung disease and Sjögren's syndrome in primary biliary cirrhosis: a causal or casual association? Clin Rheumatol (2008) 0.82
Quality of life and everyday activities in patients with primary biliary cirrhosis. Hepatology (2007) 0.80
The epidemiology of primary biliary cirrhosis in southern Israel. Isr Med Assoc J (2005) 0.80
Research on liver regeneration as an answer to the shortage of donors for liver transplantation. Hepatol Res (2014) 0.80
Major histocompatibility complex class-II alleles in primary biliary cirrhosis. Scand J Immunol (1994) 0.80
Clinical and serological profile of primary biliary cirrhosis in young and elderly patients. QJM (2008) 0.77